NICE, Social Values, and Balancing Objectivity and Equity
- 期刊名称PharmacoEconomics
- 作者Hill, Suzanne R.; Olson, Leslie G.
- 卷第32卷
- 期第11期
- 印刷ISSN1170-7690
- 电子ISSN1179-2027
- 文件大小175.38KB
- 发表时间2014-11
- DOI10.1007/s40273-014-0220-4
- 页码1039-1041
Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cellsE. Erdal; F. Bartels; T. Binscheck; G. Erdmann; J. Frevert; A. Kistner; U. Weller; J. Wever; H. Bigalke; Jürgen Frevert · 1995
Xeomin® is free from complexing proteinsFrevert Jürgen · 2008
Xeomin is free from complexing proteinsJürgen Frevert · 2009
Author’s ReplyJürgen Frevert · 2011
Botulinum A toxins: units versus unitsK. Wohlfarth; Hilke Göschel; Jürgen Frevert; Reinhard Dengler; H. Bigalke · 1997
Purification of Glyoxysomal Acetyl-CoA AcyltransferaseFREVERT, Jürgen; KINDL, Helmut · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · 1980
Selective uptake by glyoxysomes of in vitro translated malate synthaseCornelia Kruse; Jürgen Frevert; Helmut Kindl · 1981
Properties of a chimeric BoNT/A1-A4Scheps, Daniel; Schmidt, Michael; Hofmann, Fred; Jurk, Marcel; López de la Paz, Manuela; Frevert, Jürgen · Toxicon · 2016
Neramexane&NA; · Drugs in R & D · 2002
Acknowledgement to RefereesAnton van Rensburg · Drugs in R&D · 2013
Etravirine&NA;, · Drugs in R & D · 2006
Transplant RejectionStephen G. Coleman,Richelle Paterson · Drugs in R&D · 1999
BTI 322Drugs in R&D · 1999
Campath-1GDrugs in R&D · 1999
CHH 380Drugs in R&D · 1999
EtanerceptDrugs in R&D · 1999